LY-367265 is a drug developed by Eli Lilly which acts as both a potent and selective antagonist at the serotonin 5-HT2A receptor and also a selective serotonin reuptake inhibitor (SSRI). It has antidepressant effects in animal studies reduces glutamate signalling in the brain and increases the analgesic effects of morphine.
This page contains content from the copyrighted Wikipedia article "LY-367265"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
